Evidence map›Paper›PMID 35678795›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2022

Cellular and Molecular Mechanism of Cell Proliferation in Human Gastric Cancer Drug-Resistant Cells After Hyperthermia and Cisplatin: Role of mRNAs and Long-Non-coding RNAs.

Firoozeh Abolhasani Zadeh, Mina AkbariRad, HuoJun Lian, Ying Wei, Jing Yang, Xiaoke Feng, Reza Akhavan-Sigari

Open access · diamondAbstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Firoozeh Abolhasani ZadehDepartment of Surgery, Kerman University of Medical Sciences Faculty of Medicine, Kerman, Iran.
Mina AkbariRadDepartment of Internal Medicine, Mashhad University of Medical Sciences Faculty of Medicine, Mashhad, Iran.
HuoJun LianDepartment of Gastroenterology, Shangrao People's Hospital, Jiangxi Province, China; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing City, China.
Ying WeiDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing City, China; Department of Pathology, Shangrao People's Hospital, Jiangxi Province, China.
Jing YangDepartment of Pathology, Shangrao People's Hospital, Jiangxi Province, China; Department of Gastroenterology, Shangrao People's Hospital, Jiangxi Province, China.
Xiaoke FengDepartment of Gastroenterology, Shangrao People's Hospital, Jiangxi Province, China; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing City, China.
Reza Akhavan-SigariDepartment of Neurosurgery, University Medical Center, Tuebingen, Germany.
Nanjing Traditional Chinese Medicine Hospital · CNKerman University of Medical Sciences · IRMashhad University of Medical Sciences · IRShangrao Normal University · CNUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince thermo-chemotherapy was suggested as an effective treatment for gastric cancer, we aimed to evaluate the effects of hyperthermia combined with cisplatin (DDP) on the inhibition of human gastric cancer drug-resistant cells in vitro and explore its possible mechanisms.

methodsSGC-7901/DDP cells were cultured and divided into control, cisplatin, hyperthermia, and hyperthermia combined with cispla- tin groups. Hyperthermia was done at 42°C, 44°C, 46°C, 48°C, and 50°C for 12 h, 24 h, 36 h; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- 2H-tetrazolium bromide (MTT) assay detected the proliferation of SGC-7901/DDP at different time and temperature, and the apoptotic rate of SGC-7901/DDP cells was evaluated by using Annexin staining assay. High-throughput Chromatin immunoprecipitation (ChIP)- seq was applied to test long non-coding RNA expression in SGC-7901/DDP cells. Then, real-time fluorescence quantitative polymerase chain reaction was used to verify the expression of long non-coding RNA in all groups.

resultsDouble staining showed that hyperthermia combined with cisplatin increased the rate of early apoptosis of SGC-7901/DDP cells. Long non-coding RNA high-throughput ChIP-seq showed a significantly larger amount of long non-coding RNAs and mRNAs in the cells treated with hyperthermia combined cisplatin group in comparison with the control group. We observed that the upregulated mRNAs and long non-coding RNAs were highly related to immune system response and CD95 signaling pathway in nucleus, and down- regulated mRNAs and long non-coding RNA were highly related to Mammalian target of rapamycin (mTOR) and Tumor necrosis factor (TNF) receptor signaling pathway in cytoplasm.

conclusionHyperthermia combined with cisplatin reversed the expression of a large number of mRNAs and long non-coding RNAs in human gastric cancer drug-resistant cells. The molecular mechanism of inhibiting the proliferation of human gastric cancer drug- resistant cells may be related to the upregulation of long non-coding RNAs and mRNAs contributed in CD95, mTOR, and TNF receptor signaling pathway.

Indexed as

Antineoplastic AgentsHyperthermia, InducedRNA, Long NoncodingStomach NeoplasmsApoptosisCell ProliferationCisplatinDrug Resistance, NeoplasmHumansRNA, MessengerTOR Serine-Threonine KinasesAntineoplastic AgentsCisplatinRNA, Long NoncodingRNA, MessengerTOR Serine-Threonine Kinases

Identifiers

PMID35678795
PMCPMC11158417
OpenAlexW4281553421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.